Health

Phaxiam

Phaxiam is a biotechnology company developing antibacterial treatments based on the use of phages to fight bacterial infections in humans, particularly those resistant to antibiotics
Industry
BioTech
Year invested
2018
Status
IPO on Euronext (ALPHE)
Active
Other investors
Omnes, Go Capital, Auriga
Location
France